anti-estrogens (AVAX)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameanti-estrogens (AVAX)
Drug Alias Namecancer therapy (AVAX)6-Methyl-1,3,8-trichlorodibenzofuranNSC-7223026-MCDF
ClassificationSmall molecules
Mechanisms of ActionEstrogen receptors antagonists
TargetsEstrogen receptors
Therapy Area/IndicationsSolid tumoursBreast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTexas A&M University System
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAvax Technologies Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursBreast NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A